Development of a multi-analyte diagnostic assay to improve the risk stratification of indeterminate thyroid nodules
开发多分析物诊断测定法以改善不确定甲状腺结节的风险分层
基本信息
- 批准号:10545522
- 负责人:
- 金额:$ 87.12万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-08-15 至 2024-07-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAffectAntibodiesAutopsyAwardBenchmarkingBenignBiologicalBiological AssayBiological MarkersBiological SciencesBiopsyBiopsy SpecimenCategoriesCellsClinicClinicalClinical ManagementCollaborationsContractsCooperative Human Tissue NetworkCytologyDNA Sequence AlterationDataDetectionDevelopmentDiagnosisDiagnosticDiagnostic ImagingDiagnostic testsDiseaseDocumentationEarly DiagnosisExcisionFeasibility StudiesFine needle aspiration biopsyFluorogenic SubstrateFrequenciesGenetic RiskGenomicsGoalsGoldGuidelinesImageIndianaIndustry StandardInstitutional Review BoardsInvestigationLaboratoriesLesionMalignant - descriptorMalignant NeoplasmsMalignant neoplasm of thyroidMeasuresMolecularMolecular AnalysisMonitorNoduleNucleotidesOperative Surgical ProceduresPathologicPathologyPatient riskPatientsPeptide HydrolasesPerformancePersonsPhasePredictive ValuePrevalenceProspective cohortProteinsProteolysisProteomicsReadinessReportingResectedRetrospective cohortRiskRisk MarkerSamplingScienceScientific Advances and AccomplishmentsSensitivity and SpecificitySourceSpecificityTechnologyTestingThyroid GlandThyroid NoduleThyroidectomyTissue SampleTissuesUltrasonographyUnited StatesUniversitiesUnnecessary SurgeryValidationWorkbasebiobankbiomarker discoverycancer invasivenessclinical centerclinical decision-makingclinical practicecohortcommercializationcostdetection limitdiagnostic accuracydiagnostic assaydiagnostic biomarkerdiagnostic toolenzyme activityimprovedinnovationmortalitynovel markerpatient stratificationprecision medicinepremalignantprognosticprogramsprospectiverapid testrisk stratificationstandard of caretoolultrasoundvalidation studies
项目摘要
Abstract
Widespread use of sensitive imaging in clinical practice has resulted in incidental thyroid nodules
being discovered with increasing frequency, creating a unique opportunity to detect and remove
lesions at early stages of malignancy. The majority of these incidental nodules remain benign and
asymptomatic, but 10-20% are found to be malignant on surgical excision, resulting in a critical need
for improved diagnostics, as 75% of patients currently undergo unnecessary thyroidectomies to
remove benign nodules. The current standard of care includes collecting a tissue biopsy by
ultrasound-guided fine needle aspiration: these samples are tested by cytology, which looks for
aberrant cells, and for genetic risk markers. These diagnostic tests are characterized by poor
specificity, and a third of all tested nodules are still classified as indeterminate and need to be
resected for a pathological diagnosis. We originally hypothesized that dysregulated proteolysis, a
type of enzyme activity that is a hallmark of invasive cancer, might yield discriminating levels of
activity in FNA tissue from benign and malignant nodules. In Phase I work, we leveraged the Alaunus
Biosciences, Inc. diagnostic pipeline, a platform that allows innovative proteomics-based biomarker
discovery, to identify and characterize a set of protease activities (functional markers) that are
significantly increased in malignant nodules. We then developed fluorogenic substrate assays to
monitor these activities using small volumes of biological samples. In parallel, we also discovered
additional mass-based markers that can be measured with standard antibody-based assays. Our
investigational multi-analyte diagnostic assay has the potential to differentiate malignant from benign
thyroid tissue with sensitivity and specificity >90%. In this Phase II proposal, we aim to perform
technical and clinical validation studies required to advance the assay to readiness for clinical use in
the early diagnosis of indeterminate thyroid nodules. In Aim 1, we will benchmark the clinical utility of
our selected protein and functional biomarkers in surgical tissue to evaluate scoring, establish
diagnostic thresholds, and report on key assay parameters. In Aim 2, we will perform a
comprehensive technical assessment of the laboratory performance of the assay to satisfy industry
standards. In Aim 3, we will create an independent cohort of FNA tissue samples, through our IRB-
approved biobanking efforts at UCSF, UCLA and IU, to be used for a robust prospective validation of
the clinical usefulness of the assay. Our goal is to develop a rapid assay that improves patient
stratification over current standard diagnostic markers, guides clinical decision-making to avoid
unnecessary surgical intervention, and transforms the clinical management of these challenging
lesions.
摘要
在临床实践中广泛使用的敏感成像导致了偶发性甲状腺结节
被发现的频率越来越高,创造了一个独特的机会,以检测和删除
恶性肿瘤早期病变。大多数偶发结节仍为良性,
无症状,但10 - 20%被发现是恶性手术切除,导致急需
为了改善诊断,目前75%的患者接受不必要的甲状腺切除术,
切除良性结节。目前的护理标准包括通过以下方式收集组织活检:
超声引导细针穿刺:这些样本通过细胞学进行检测,
异常细胞和遗传风险标记。这些诊断测试的特点是穷人
特异性,三分之一的测试结核仍然被归类为不确定的,需要
切除以进行病理诊断。我们最初假设蛋白水解失调,
一种酶活性是侵袭性癌症的标志,可能会产生不同水平的
良性和恶性结节的FNA组织中的活性。在第一阶段的工作中,我们利用了Allaunus
Biosciences,Inc.诊断管道,一个平台,允许创新的基于蛋白质组学的生物标志物
发现,以鉴定和表征一组蛋白酶活性(功能标记物),
恶性结节显著增加。然后,我们开发了荧光底物测定,
使用少量生物样品监测这些活动。同时,我们还发现
可以用标准的基于抗体的测定法测量的另外的基于质量的标记物。我们
研究性多分析物诊断测定具有区分恶性与良性的潜力
甲状腺组织的敏感性和特异性> 90%。在第二阶段的提案中,我们的目标是执行
技术和临床验证研究,以将检测试剂盒推向临床使用,
甲状腺结节的早期诊断在目标1中,我们将对
我们在手术组织中选择的蛋白质和功能性生物标志物来评估评分,
诊断阈值,并报告关键检测参数。在目标2中,我们将执行
对检测试剂盒的实验室性能进行全面的技术评估,以满足行业要求
标准在目标3中,我们将通过我们的IRB创建一个独立的FNA组织样本队列-
在UCSF、UCLA和IU批准的生物库工作,用于对以下内容进行稳健的前瞻性验证:
分析的临床实用性。我们的目标是开发一种快速检测方法,
对当前标准诊断标志物进行分层,指导临床决策,以避免
不必要的手术干预,并改变这些具有挑战性的临床管理
病变
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
GISELLE M KNUDSEN其他文献
GISELLE M KNUDSEN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('GISELLE M KNUDSEN', 18)}}的其他基金
Development of a multi-analyte diagnostic assay to improve the risk stratification of indeterminate thyroid nodules
开发多分析物诊断测定法以改善不确定甲状腺结节的风险分层
- 批准号:
10684875 - 财政年份:2022
- 资助金额:
$ 87.12万 - 项目类别:
Development of activity-based biomarkers for risk stratification of indeterminate thyroid nodules
开发基于活动的生物标志物,用于不确定甲状腺结节的风险分层
- 批准号:
10080280 - 财政年份:2020
- 资助金额:
$ 87.12万 - 项目类别:
Geldanamycin-Mediated Uptake of Nanoparticle Probes
格尔德霉素介导的纳米颗粒探针的摄取
- 批准号:
7151736 - 财政年份:2006
- 资助金额:
$ 87.12万 - 项目类别:
Geldanamycin-Mediated Uptake of Nanoparticle Probes
格尔德霉素介导的纳米颗粒探针的摄取
- 批准号:
7493914 - 财政年份:2006
- 资助金额:
$ 87.12万 - 项目类别:
CHARACTERIZATION OF CARBORANE CONTAINING POLYPEPTIDES
含碳硼烷多肽的表征
- 批准号:
6119195 - 财政年份:1999
- 资助金额:
$ 87.12万 - 项目类别:
CHARACTERIZATION OF CARBORANE CONTAINING POLYPEPTIDES
含碳硼烷多肽的表征
- 批准号:
6280216 - 财政年份:1998
- 资助金额:
$ 87.12万 - 项目类别:
相似海外基金
How Does Particle Material Properties Insoluble and Partially Soluble Affect Sensory Perception Of Fat based Products
不溶性和部分可溶的颗粒材料特性如何影响脂肪基产品的感官知觉
- 批准号:
BB/Z514391/1 - 财政年份:2024
- 资助金额:
$ 87.12万 - 项目类别:
Training Grant
BRC-BIO: Establishing Astrangia poculata as a study system to understand how multi-partner symbiotic interactions affect pathogen response in cnidarians
BRC-BIO:建立 Astrangia poculata 作为研究系统,以了解多伙伴共生相互作用如何影响刺胞动物的病原体反应
- 批准号:
2312555 - 财政年份:2024
- 资助金额:
$ 87.12万 - 项目类别:
Standard Grant
RII Track-4:NSF: From the Ground Up to the Air Above Coastal Dunes: How Groundwater and Evaporation Affect the Mechanism of Wind Erosion
RII Track-4:NSF:从地面到沿海沙丘上方的空气:地下水和蒸发如何影响风蚀机制
- 批准号:
2327346 - 财政年份:2024
- 资助金额:
$ 87.12万 - 项目类别:
Standard Grant
Graduating in Austerity: Do Welfare Cuts Affect the Career Path of University Students?
紧缩毕业:福利削减会影响大学生的职业道路吗?
- 批准号:
ES/Z502595/1 - 财政年份:2024
- 资助金额:
$ 87.12万 - 项目类别:
Fellowship
感性個人差指標 Affect-X の構築とビスポークAIサービスの基盤確立
建立个人敏感度指数 Affect-X 并为定制人工智能服务奠定基础
- 批准号:
23K24936 - 财政年份:2024
- 资助金额:
$ 87.12万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Insecure lives and the policy disconnect: How multiple insecurities affect Levelling Up and what joined-up policy can do to help
不安全的生活和政策脱节:多种不安全因素如何影响升级以及联合政策可以提供哪些帮助
- 批准号:
ES/Z000149/1 - 财政年份:2024
- 资助金额:
$ 87.12万 - 项目类别:
Research Grant
How does metal binding affect the function of proteins targeted by a devastating pathogen of cereal crops?
金属结合如何影响谷类作物毁灭性病原体靶向的蛋白质的功能?
- 批准号:
2901648 - 财政年份:2024
- 资助金额:
$ 87.12万 - 项目类别:
Studentship
Investigating how double-negative T cells affect anti-leukemic and GvHD-inducing activities of conventional T cells
研究双阴性 T 细胞如何影响传统 T 细胞的抗白血病和 GvHD 诱导活性
- 批准号:
488039 - 财政年份:2023
- 资助金额:
$ 87.12万 - 项目类别:
Operating Grants
New Tendencies of French Film Theory: Representation, Body, Affect
法国电影理论新动向:再现、身体、情感
- 批准号:
23K00129 - 财政年份:2023
- 资助金额:
$ 87.12万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The Protruding Void: Mystical Affect in Samuel Beckett's Prose
突出的虚空:塞缪尔·贝克特散文中的神秘影响
- 批准号:
2883985 - 财政年份:2023
- 资助金额:
$ 87.12万 - 项目类别:
Studentship